These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18991566)

  • 21. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
    Subramanian N; Kanwar JR; Kanwar RK; Krishnakumar S
    Nucleic Acid Ther; 2015 Dec; 25(6):317-22. PubMed ID: 26334953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.
    Wang CW; Chung WH; Cheng YF; Ying NW; Peck K; Chen YT; Hung SI
    J Allergy Clin Immunol; 2013 Sep; 132(3):713-722.e11. PubMed ID: 23791505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bivalent aptamer and terminus-free siRNA junction nanostructure for targeted gene silencing in cancer cells.
    Yang F; Li S; Yuan R; Xiang Y
    J Mater Chem B; 2022 Oct; 10(40):8315-8321. PubMed ID: 36165395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
    Aliabadi HM; Mahdipoor P; Uludağ H
    Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer.
    Liu HY; Yu X; Liu H; Wu D; She JX
    Sci Rep; 2016 Jul; 6():30346. PubMed ID: 27456457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aptamer-targeted RNAi for HIV-1 therapy.
    Zhou J; Rossi JJ
    Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells.
    Dong J; Cao Y; Shen H; Ma Q; Mao S; Li S; Sun J
    Biomed Pharmacother; 2018 Nov; 107():849-859. PubMed ID: 30142547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular delivery of RNA-based therapeutics using aptamers.
    Thiel KW; Giangrande PH
    Ther Deliv; 2010 Dec; 1(6):849-61. PubMed ID: 21643487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photomodulating Gene Expression by Using Caged siRNAs with Single-Aptamer Modification.
    Zhang L; Chen C; Fan X; Tang X
    Chembiochem; 2018 Jun; 19(12):1259-1263. PubMed ID: 29488297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.
    Liang C; Guo B; Wu H; Shao N; Li D; Liu J; Dang L; Wang C; Li H; Li S; Lau WK; Cao Y; Yang Z; Lu C; He X; Au DW; Pan X; Zhang BT; Lu C; Zhang H; Yue K; Qian A; Shang P; Xu J; Xiao L; Bian Z; Tan W; Liang Z; He F; Zhang L; Lu A; Zhang G
    Nat Med; 2015 Mar; 21(3):288-94. PubMed ID: 25665179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.
    Zhou J; Rossi JJ
    BioDrugs; 2012 Dec; 26(6):393-400. PubMed ID: 23046156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
    Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
    Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge.
    Zhou J; Neff CP; Swiderski P; Li H; Smith DD; Aboellail T; Remling-Mulder L; Akkina R; Rossi JJ
    Mol Ther; 2013 Jan; 21(1):192-200. PubMed ID: 23164935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.
    Mohammadi M; Salmasi Z; Hashemi M; Mosaffa F; Abnous K; Ramezani M
    Int J Pharm; 2015 May; 485(1-2):50-60. PubMed ID: 25712164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells.
    Ayatollahi S; Salmasi Z; Hashemi M; Askarian S; Oskuee RK; Abnous K; Ramezani M
    Int J Biochem Cell Biol; 2017 Nov; 92():210-217. PubMed ID: 29031805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.
    Zhou J; Satheesan S; Li H; Weinberg MS; Morris KV; Burnett JC; Rossi JJ
    Chem Biol; 2015 Mar; 22(3):379-90. PubMed ID: 25754473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.